Speakers
Conference Co-Chairs
Bob Go, Vice Chairman, Deloitte LLP
Andrew Jack, Pharmaceuticals Correspondent, Financial Times
Keynote(s)
The Rt Hon David Cameron MP, Prime Minister of the United Kingdom,
Neil de Crescenzo, SVP and General Manager Health Sciences Global Business Unit, Oracle Corporation
Dr Mehmood Khan, CEO, Global Nutrition Group and Chief Scientific Officer, PepsiCo
Dr Jörg Reinhardt, Chairman of the Board of Management, Bayer HealthCare AG
Lars Rebien Sørensen, President and CEO, Novo Nordisk A/S
Dr Severin Schwan, CEO, Roche Group
Speaker(s)
Kian Teik Beh, International Director Europe, Singapore Economic Development Board
Darren Campili, Head of EMEA Healthcare, Deutsche Bank AG
Sir David Cooksey GBE, Chairman, The Francis Crick Institute
Dr Francesco De Rubertis, Partner, Index Ventures
Dr Samantha Du, Founder and Former CEO, Hutchison MediPharma Ltd
Prof Michel Goldman, Executive Director, Innovative Medicines Initiative (IMI)
Alex Gorsky, Vice Chairman, Executive Committee, Johnson & Johnson
Jane Griffiths, Company Group Chairman, Janssen EMEA
Rajiv Gulati, President - Global Pharmaceutical Business, Ranbaxy Laboratories Ltd
Dr Margaret A. Hamburg, Commissioner, U.S. Food and Drugs Administration
Simon Hammett, EMEA Head of Healthcare & Life Sciences, Deloitte LLP
Jamie Heywood, Co-founder and Chairman, PatientsLikeMe
Steve H. Holtzman, EVP Corporate Development, Biogen Idec
Brian Horsburgh, Head of Life Sciences, IP Group
Nigel Jones, Co-Head, Healthcare Sector , Linklaters
The Rt Hon Andrew Lansley MP, Secretary of State for Health, UK Government
Alan Levin, EVP and CFO, Endo Pharmaceuticals, Inc
Dr Stephen Little, VP Personalized Healthcare, QIAGEN
Vladimir Makatsaria, President, Johnson & Johnson, Ethicon, Johnson & Johnson
Dr John Pottage, Chief Scientific and Medical Officer, ViiV Healthcare
David Redfern, Chief Strategy Officer, GlaxoSmithKline
Dr Michael Rosenblatt, MD, Chief Medical Officer and EVP, Merck
Brent Saunders, CEO, Bausch + Lomb
Rolf Soderstom, CFO, BTG plc
Miles D White, Chairman of the Board and CEO, Abbott
Alun Wilcox, Director of Medical, PDD Group Ltd
Dr Klaus Wilgenbus, Corporate SVP, Boehringer Ingelheim GmbH
Professor Sir Kent Woods, Chief Executive, Medicines and Healthcare products Regulatory Agency and Chairman of the Management Board, European Medicines Agency
Tony Zook, EVP Global Commercial, AstraZeneca
Panelist(s)
Dame Sally Davies DBE, Director General of Research and Development and Chief Scientific Adviser for the Department of Health and National Health Service,
Sir David Nicholson KCB, CBE, CEO, National Health Service
The Rt Hon David Willetts MP, Minister of State for Universities & Science,
